Mutations of CEBPA in acute myeloid leukemia FAB types M1 and M2

Genes Chromosomes and Cancer

Volumn 37, Issue 1, 2003, Pages 72-78

  Snaddon, Jennifer ^a   Smith, Matthew L ^a   Neat, Michael ^a   Cambal Parrales, Maxine ^a   Dixon McIver, Amanda ^a   Arch, Rachael ^a   Amess, John A ^a   Rohatiner, Ama Z ^a   Lister, T Andrew ^a   Fitzgibbon, Jude ^a,b  

^a ST BARTHOLOMEW S HOSPITAL   (United Kingdom)

^b IMPERIAL CANCER RESEARCH FUND   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CCAAT ENHANCER BINDING PROTEIN ALPHA;

ACUTE GRANULOCYTIC LEUKEMIA; ADULT; AGED; ALLELISM; ARTICLE; CARBOXY TERMINAL SEQUENCE; CELL DIFFERENTIATION; CYTOGENETICS; FEMALE; FLUORESCENCE IN SITU HYBRIDIZATION; GENE DELETION; GENE LOCUS; GENE MUTATION; GRANULOCYTE; HOMOZYGOSITY; HUMAN; KARYOTYPE; LEUKEMIA; MAJOR CLINICAL STUDY; MALE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROGNOSIS; SEQUENCE ANALYSIS; SINGLE STRAND CONFORMATION POLYMORPHISM;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; AMINO ACID SEQUENCE; CCAAT-ENHANCER-BINDING PROTEIN-ALPHA; DNA MUTATIONAL ANALYSIS; DNA, NEOPLASM; FEMALE; HUMANS; LEUCINE ZIPPERS; LEUKEMIA, MYELOCYTIC, ACUTE; MALE; MIDDLE AGED; MOLECULAR SEQUENCE DATA; MUTATION; RISK FACTORS;

EID: 0345269758     PISSN: 10452257     EISSN: None     Source Type: Journal    
DOI: 10.1002/gcc.10185     Document Type: Article

References (25)

1. Agre P, Johnson PF, McKnight SL. 1989. Cognate DNA binding specificity retained after leucine zipper exchange between GCN4 and C/EBP. Science 246:922-926.
2. Behre GSS, Liu H, Bortolin LT, Christopeit M, Radomska HS, Rangatia J, Hiddemann W, Friedman AD, Tenen DG. 2002. Ras signaling enhances the activity of C/EBP alpha to induce granulocytic differentiation by phosphorylation of serine 248. J Biol Chem 277:26293-26299.
3. Brandt-Rauf PW, Chen JM, Lee G. 1989. Conformational energy analysis of the leucine repeat regions of C/EBP, GCN4, and the proteins of the myc, jun, and fos oncogenes. J Protein Chem 8:679-688.
4. Downing J. 1999. The AML1-ETO chimaeric transcription factor in acute myeloid leukaemia: biology and clinical significance. Br J Haematol 106:296-308.
5. Erickson P, Gao J, Chang KS, Look T, Whisenant E, Raimondi S, Lasher R, Trujillo J, Rowley J, Drabkin H. 1992. Identification of breakpoints in t(8;21) acute myelogenous leukemia and isolation of a fusion transcript, AML1/ETO, with similarity to Drosophila segmentation gene, runt. Blood 80:1825-1831.
6. Gombart A, Hofmann WK, Kawano S, Takeuchi S, Krug U, Kwok SH, Larsen RJ, Asou H, Miller CW, Hoelzer D, Koeffler HP. 2002. Mutations in the gene encoding the transcription factor CCAAT/enhancer binding protein alpha in myelodysplastic syndromes and acute myeloid leukemias. Blood 99:1332-1340.
7. Grimwade D. 2001. The clinical significance of cytogenetic abnormalities in acute myeloid leukaemia. Best Pract Res Clin Haematol 14:497-529.
8. Hendricks-Taylor L, Bachinski LL, Siciliano MJ, Fertitta A, Trask B, de Jong PJ, Ledbetter DH, Darlington GJ. 1992. The CCAAT/ enhancer binding protein (C/EBP alpha) gene (CEBPA) maps to human chromosome 19q13.1 and the related nuclear factor NF-IL6 (C/EBP beta) gene (CEBPB) maps to human chromosome 20q13.1. Genomics 14:12-17.
9. Hiebert S. 2001. Differentiation or leukemia: is C/EBPalpha the answer? Nat Med 7:407-408.
10. Hohaus S, Petrovick MS, Voso MT, Sun Z, Zhang DE, Tenen DG. 1995. PU.1 (Spi-1) and C/EBP alpha regulate expression of the granulocyte-macrophage colony-stimulating factor receptor alpha gene. Mol Cell Biol 15:5830-5845.
11. Imai Y, Kurokawa M, Izutsu K, Hangaishi A, Takeuchi K, Maki K, Ogawa S, Chiba S, Mitani K, Hirai H. 2000. Mutations of the AML1 gene in myelodysplastic syndrome and their functional implications in leukemogenesis. Blood 96:3154-3160.
12. Johansen LMIA, Lodie TA, Sasaki K, Felsher DW, Golub TR, Tenen DG. 2001. c-Myc is a critical target for c/EBPalpha in granulopoiesis. Mol Cell Biol 21:3789-3806.
13. Langabeer S, Walker H, Rogers JR, Burnett AK, Wheatley K, Swirsky D, Goldstone AH, Linch DC. 1999. Incidence of AML1/ ETO fusion transcripts in patients entered into the MRC AML trials. MRC Adult Leukaemia Working Party. Br J Haematol 99:925-928.
14. Nucifora G, Birn DJ, Erickson P, Gao J, LeBeau MM, Drabkin HA, Rowley JD. 1993. Detection of DNA rearrangements in the AML1 and ETO loci and of an AML1/ETO fusion mRNA in patients with t(8;21) acute myeloid leukemia. Blood 81:883-888.
15. Oelgeschlager M, Nuchprayoon I, Luscher B, Friedman AD. 1996. C/EBP, c-Myb, and PU.1 cooperate to regulate the neutrophil elastase promoter. Mol Cell Biol 16:4717-4725.
16. Osato M, Asou N, Abdalla E, Hoshino K, Yamasaki H, Okubo T, Suzushima H, Takatsuki K, Kanno T, Shigesada K, Ito Y. 1999. Biallelic and heterozygous point mutations in the runt domain of the AML1/PEBP2alphaB gene associated with myeloblastic leukemias. Blood 96:1817-1824.
17. Pabst T, Mueller BU, Zhang P, Radomska HS, Narravula S, Schnittger S, Behre G, Hiddemann W, Tenen DG. 2001a. Dominant-negative mutations of CEBPA, encoding CCAAT/enhancer binding protein-alpha (C/EBPalpha), in acute myeloid leukemia. Nat Genet 27:263-270.
18. Pabst T, Mueller BU, Harakawa N, Schoch C, Haferlach T, Behre G, Hiddemann W, Zhang DE, Tenen DG. 2001b. AML1-ETO downregulates the granulocytic differentiation factor C/EBPalpha in t(8;21) myeloid leukemia. Nat Med 7:444-451.
19. Petrovick M, Hiebert SW, Friedman AD, Hetherington CJ, Tenen DG, Zhang DE. 1998. Multiple functional domains of AML1: PU.1 and C/EBPalpha synergize with different regions of AML1. Mol Cell Biol 18:3915-3925.
20. Preudhomme C, Warot-Loze D, Roumier C, Grardel-Duflos N, Garand R, Lai JL, Dastugue N, Macintyre E, Denis C, Bauters F, Kerckaert JP, Cosson A, Fenaux P. 2000. High incidence of biallelic point mutations in the Runt domain of the AML1/PEBP2 alpha B gene in MO acute myeloid leukemia and in myeloid malignancies with acquired trisomy 21. Blood 96:2862-2869.
21. Smith L, Hohaus S, Gonzalez DA, Dziennis SE, Tenen DG. 1996. PU.1 (Spi-1) and C/EBP alpha regulate the granulocyte colony-stimulating factor receptor promoter in myeloid cells. Blood 88:1234-1247.
22. Snaddon J, Neat M, Smith ML, Amess JA, Rohatiner AZ, Lister TA, Fitzgibbon J. 2002. Mutations in the Runt homology domain of CBFA2 in myeloid malignancies with acquired trisomy 21. Cancer Genet Cytogenet 136:151-152.
23. Vinson C, Sigler PB, McKnight SL. 1989. Scissors-grip model for DNA recognition by a family of leucine zipper proteins. Science 246:911-916.
24. Zhang D, Hetherington CJ, Meyers S, Rhoades KL, Larson CJ, Chen HM, Hiebert SW, Tenen DG. 1996. CCAAT enhancer-binding protein (C/EBP) and AML1 (CBF alpha2) synergistically activate the macrophage colony-stimulating factor receptor promoter. Mol Cell Biol 16:1231-1240.
25. Zhang D, Zhang P, Wang ND, Hetherington CJ, Darlington GJ, Tenen DG. 1997. Absence of granulocyte colony-stimulating factor signaling and neutrophil development in CCAAT enhancer binding protein alpha-deficient mice. Proc Natl Acad Sci USA 94:569-574.